Breaking News Instant updates and real-time market news.

KOS

Kosmos

$6.30

0.1 (1.61%)

05:21
11/04/19
11/04
05:21
11/04/19
05:21

Kosmos reports Q3 EPS 4c, consensus 2c

Reports Q3 revenue $356.97M, consensus $394.3M. Reports Q3 sales of 6M boe. "Kosmos continued to build momentum in the third quarter with strong free cash flow delivery and exploration success," said Andrew Inglis, chairman and CEO. "At current oil prices we expect to deliver the 2019 free cash flow we set out at our capital markets day in February. Our 2019 drilling program in Mauritania and Senegal has increased the gas initially in place to the top end of our 50-100 Tcf range. Furthermore, our first infrastructure-led exploration well in Equatorial Guinea was successful and we expect this to further enhance the value of our Equatorial Guinea acquisition."

  • 04

    Nov

KOS Kosmos
$6.30

0.1 (1.61%)

12/21/18
EVER
12/21/18
NO CHANGE
Target $42
EVER
Outperform
Golar LNG Tortue project worth $10 per share to equity, says Evercore ISI
After Kosmos Energy (KOS) and BP (BP), the equity owners in the Greater Tortue Ahmeyim project offshore Senegal and Mauritania, announced Final Investment Decision on Phase 1, which will utilize one of Golar LNG's (GLNG) FLNG vessels, Evercore ISI analyst Jonathan Chappell said he continues to estimate a nearly $10/share value to Golar LNG equity based on the expected output, start-up time, and financing. Stating that Tortue means "an awful lot" for Golar LNG, he reiterated his Outperform rating on the stock and trimmed his target to $42 from $43.
01/04/19
BERN
01/04/19
UPGRADE
BERN
Outperform
Kosmos upgraded to Outperform from Market Perform at Bernstein
01/04/19
BERN
01/04/19
UPGRADE
BERN
Outperform
Kosmos upgraded to Outperform from Market Perform at Bernstein
Bernstein analyst Bob Brackett upgraded Kosmos Energy to Outperform from Market Perform, telling investors in a research note that this is a great entry point for a new strategy and a "deep" pool of free cash flow.
05/01/19
MACQ
05/01/19
INITIATION
MACQ
Outperform
Kosmos initiated with an Outperform at Macquarie

TODAY'S FREE FLY STORIES

GD

General Dynamics

$182.38

4.26 (2.39%)

17:30
12/05/19
12/05
17:30
12/05/19
17:30
Hot Stocks
General Dynamics awarded $145.75M Navy contract modification »

General Dynamics was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

17:28
12/05/19
12/05
17:28
12/05/19
17:28
Hot Stocks
DocuSign up 8.5% to $75.38 after Q3 results beat estimates »

The company also raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

  • 16

    Dec

DASTY

Dassault Systemes

$0.00

(0.00%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Initiation
Dassault Systemes initiated  »

Dassault Systemes resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Hot Stocks
Ulta Beauty up 10% to $259.20 after Q3 profit beat estimates »

The company also narrowed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AUMN

Golden Minerals

$0.30

0.0089 (3.07%)

17:21
12/05/19
12/05
17:21
12/05/19
17:21
Syndicate
Breaking Syndicate news story on Golden Minerals »

Golden Minerals files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$16.62

0.065 (0.39%)

17:18
12/05/19
12/05
17:18
12/05/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Yext »

Yext down 21% to $13.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FIZZ

National Beverage

$48.28

-1.16 (-2.35%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Earnings
National Beverage reports Q2 EPS 70c, consensus 68c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$34.49

1.58 (4.80%)

17:15
12/05/19
12/05
17:15
12/05/19
17:15
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONDS

Ondas Holdings

$0.00

(0.00%)

17:12
12/05/19
12/05
17:12
12/05/19
17:12
Syndicate
Breaking Syndicate news story on Ondas Holdings »

Ondas Holdings files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GH

Guardant Health

$73.57

-1.43 (-1.91%)

17:11
12/05/19
12/05
17:11
12/05/19
17:11
Hot Stocks
Guardant Health Chief Medical Officer Richard Lanman to retire »

On December 2, Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$44.13

0.1 (0.23%)

17:10
12/05/19
12/05
17:10
12/05/19
17:10
Hot Stocks
Douglas Emmett raises quarterly dividend by 8% to 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Periodicals
Zoom Video shares fall on moderating revenue growth, CNBC reports »

Zoom's revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

, EIGI

Endurance

$4.04

-0.06 (-1.46%)

17:03
12/05/19
12/05
17:03
12/05/19
17:03
Hot Stocks
TripAdvisor acquires SinglePlatform from Endurance, terms not disclosed »

TripAdvisor (TRIP)…

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

EIGI

Endurance

$4.04

-0.06 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.63

-0.45 (-1.21%)

, COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

16:56
12/05/19
12/05
16:56
12/05/19
16:56
Periodicals
OPEC cancels customary press conference after meeting, CNBC reports »

Amid reports that OPEC…

BP

BP

$36.63

-0.45 (-1.21%)

COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

TOT

Total

$52.29

0.02 (0.04%)

XOM

Exxon Mobil

$68.41

-0.24 (-0.35%)

CVX

Chevron

$116.30

-0.66 (-0.56%)

RDS.A

Royal Dutch Shell

$56.50

-0.34 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

16:53
12/05/19
12/05
16:53
12/05/19
16:53
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$75.68

0.67 (0.89%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Hot Stocks
Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Earnings
Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Upgrade
Epizyme rating change  »

Epizyme upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.